1. |
1 Barlett RR, Anagnostopulos H, Zielinski T,
et al . Effects of leflunomide on immune responses and models of inflammation. Springer Semin Immunopathal , 1993, 14(4): 381-394.
|
2. |
Mldenovic V, Domljan Z, Rozman B, et al . Safety and effectiveness of leflunomide in the treatment of patients with rheumatoidarthritis. Arthritis Rheumat , 1995, 38(11): 1596-1603.
|
3. |
Smolen JS, Kalden JR, Scott DL, et al . Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoidarthritis: a double-blind, randomised, multicentre trial. Lancet , 1999, 353(9149): 259-266.
|
4. |
Felson DT, Anderson JJ, Boers M, et al . American college of rheumatology preliminary definition of improvement in rheumatoid arthrit is. Arthritis Rheumat , 1995, 38(6): 727-735.
|
5. |
孙凌云, 金欧, 王红. 来氟米特治疗类风湿关节炎的疗效评价. 南京大学学报(自然科学), 2002, 38(5): 632-635.
|
6. |
Jadad AR, Moore RA, Corral D, Assessing the quality of the reports of randomized clinical trials: is blinding necessary? control clin trials , 1996, 17(1): 1-12.
|
7. |
吕随峰, 肖飞, 何培根, 等. 爱若华治疗类风湿性关节炎的疗效及其安全性. 临床内科杂志, 2000, 11(6): 375-376.
|
8. |
李向培, 厉小梅, 汪国生, 等. 来氟米特治疗类风湿性关节炎的临床研究. 中国临床药理学与治疗学, 200l, 6 (2): 142-144.
|
9. |
张玲玲, 丁长海, 梁朝朝, 等. 来氟米特治疗类风湿关节炎随机双盲平行对照临床试验. 中国临床药理学杂志, 2005, 9, (97): 341-343.
|
10. |
Hu Y, Tu S, Liu P. A randomized, controlled, single-blind trial of leflunomide in the treatment of rheumatoid arthritis. J Tongji Med Univ , 2001, 21(1): 72-74.
|
11. |
钟清, 甘华, 陈恩静, 等. 来氟米特治疗类风湿性关节炎的临床疗效评价. 重庆医科大学学报, 2003, 28 (4): 503-505, 524.
|
12. |
帅宗文, 刘爽, 孙桂华, 等. 来氟米特治疗类风湿性关节炎的Ⅱ期临床试验. 安徽医科大学学报, 2002, 37 (1): 41-43.
|
13. |
姜林锑, 於强, 梅振武. 来氟米特治疗类风湿性关节炎的疗效评价. 中国临床医学, 2000, 7 (4): 413-415.
|
14. |
马骥良. 来氟米特和甲氨喋呤治疗活动性类风湿关节炎的对比观察. 北京医学, 2000, 22 (6): 342-345.
|
15. |
Strand V, Cohen S, Schiff M, et al . Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Arch Intern Med , 1999, 159 (21): 2542-2550.
|
16. |
Fiehn C, Jacki S, Heilig B, et al . Eight versus 16-week re-evaluation period in rheumatoid arthritis patients treated with leflunomide or methotrexate accompanied by moderate dose prednisone. Rheumatol Int , 2007, 8(27): 975–979.
|
17. |
Bao C, Chen S, Gu Y, et al . Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial. Chin Med J (Engl) , 2003, 116(8): 1228-1234.
|
18. |
Emery P, Breedveld FC, Lemmel EM, et al . A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis. Rheumatology , 2000, 39: 655-665.
|
19. |
Cohen S, Cannon GW, Schiff M, et al . Two-year, blinded, randomized, controlled trail of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Arthritis Rheum , 2001, 44(9): 1984-1992.
|
20. |
Ishaq M, Muhammad JS, Hameed K, et al . Leflunomide or methotrexate? Comparison of clinical efficacy and safety in low socio-economic rheumatoid arthritis patients. Mod Rheumatol , 2011, 1(7): 566-589.
|
21. |
Peter T, George W, Andreas M, et al . Clinical improvement as peflected in measures of function and health-related quality of life following treatment with leflunomide compare wirh methotrexate in patients with rheumatoid arthritis. Arthritis & Rheumatism , 2000, 3(43): 506–514.
|
22. |
Katayama K, Matsuno T. Long-term efficacy of leflunomide on disease activity and inhibition of joint damage: retrospective comparison with methotrexate for Japanese rheumatoid arthritis patients. Mod Rheumatol , 2009, 6(19): 513–521.
|
23. |
李金鹏, 王摇瑞, 白人骁. 来氟米特和甲氨蝶呤治疗类风湿关节炎疗效及安全性的荟萃分析. 现代中西医结合杂志, 2011, 2(6): 673-675.
|
24. |
朱湘竹, 周兴军, 陆艾芹, 等. 来氟米特治疗类风湿性关节炎疗效的Meta分析. 现代预防医学2007, 34(11): 2011-2014.
|